{"nct_id":"NCT02189733","title":"Bioequivalence of Liquid and Reconstituted Lyophilized Subcutaneous Formulations of Caplacizumab.","status":"COMPLETED","status_verified_date":"2014-07","start_date":"2014-07","start_date_type":null,"primary_completion_date":"2014-09","primary_completion_date_type":"ACTUAL","completion_date":null,"completion_date_type":null,"phases":["PHASE1"],"tickers":["SNY"]}